Multicenter Phase I Study of Repeated Intratumoral Delivery of Adenoviral p53 in Patients With Advanced Non–Small-Cell Lung Cancer EGFR exon 19 and 21 mutation status was determined in 265 tumor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results